Lv3
360 积分 2025-02-06 加入
Laboratory findings in patients treated with complement factor C3 inhibitor pegcetacoplan
1个月前
已完结
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results
2个月前
已完结
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events
2个月前
已完结
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
2个月前
已完结
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab
2个月前
已完结
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
4个月前
已完结
皖公网安备34019202002308
